Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,150.00
+8.00 (0.37%)
Oct 1, 2026, 4:39 PM GMT
Genus Market Cap
Genus has a market cap or net worth of 1.43 billion as of October 1, 2026. Its market cap has decreased by -8.63% in one year.
Market Cap
1.43B
Enterprise Value
1.50B
Revenue
658.10M
Ranking
n/a
PE Ratio
5.04
Stock Price
2,150.00
ChartMarket Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.43B, an increase of 4,519.14%. That is a compound annual growth rate of 14.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.43B | -17.45% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.77B |
| Oxford Biomedica | 623.35M |
| Avacta Group | 339.59M |
| PureTech Health | 283.43M |
| Scancell Holdings | 115.77M |
| 4basebio | 87.40M |
| Bioventix | 86.21M |
| Faron Pharmaceuticals Oy | 80.55M |